Published in J Allergy Clin Immunol on February 01, 2010
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J Clin Invest (2013) 1.60
Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS One (2011) 1.41
Immunogenicity of allogeneic mesenchymal stem cells. J Cell Mol Med (2012) 1.32
Immunoglobulin analysis tool: a novel tool for the analysis of human and mouse heavy and light chain transcripts. Front Immunol (2012) 1.25
A Temporal Model of Human IgE and IgG Antibody Function. Front Immunol (2013) 1.23
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology (2014) 1.13
Clinicopathological findings of immunoglobulin G4-related kidney disease. Clin Exp Nephrol (2011) 1.12
Location and length distribution of somatic hypermutation-associated DNA insertions and deletions reveals regions of antibody structural plasticity. Genes Immun (2012) 1.09
Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival. Glycoconj J (2011) 1.08
Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy. Mol Ther (2014) 1.07
The shape of the lymphocyte receptor repertoire: lessons from the B cell receptor. Front Immunol (2013) 1.07
Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy (2012) 1.06
Antibody WN1 222-5 mimics Toll-like receptor 4 binding in the recognition of LPS. Proc Natl Acad Sci U S A (2012) 0.99
Novel blocking human IgG directed against the pentapeptide repeat motifs of Neisseria meningitidis Lip/H.8 and Laz lipoproteins. J Immunol (2011) 0.99
Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward. Front Immunol (2014) 0.99
The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding. J Biol Chem (2012) 0.98
Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection. Eur J Immunol (2014) 0.96
Antibody modeling using the prediction of immunoglobulin structure (PIGS) web server [corrected]. Nat Protoc (2014) 0.96
Role of mutations in the cellular internalization of amyloidogenic light chains into cardiomyocytes. Sci Rep (2013) 0.96
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes. PLoS One (2013) 0.96
The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice. Int J Nanomedicine (2013) 0.95
Onset of immune senescence defined by unbiased pyrosequencing of human immunoglobulin mRNA repertoires. PLoS One (2012) 0.92
Characteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclasses. PLoS One (2013) 0.92
Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies. J Peripher Nerv Syst (2013) 0.91
A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis. J Immunol Methods (2014) 0.91
IgA response in preterm neonates shows little evidence of antigen-driven selection. J Immunol (2012) 0.90
Recent findings on the structure and function of teleost IgT. Fish Shellfish Immunol (2011) 0.90
IgE-based immunotherapy of cancer: challenges and chances. Allergy (2013) 0.89
Probing antibody internal dynamics with fluorescence anisotropy and molecular dynamics simulations. MAbs (2013) 0.89
Serum IgG subclasses in autoimmune diseases. Medicine (Baltimore) (2015) 0.89
An introduction to immunology and immunopathology. Allergy Asthma Clin Immunol (2011) 0.88
Chimeric anti-CD14 IGG2/4 Hybrid antibodies for therapeutic intervention in pig and human models of inflammation. J Immunol (2013) 0.87
Increased severity of respiratory infections associated with elevated anti-LPS IgG2 which inhibits serum bactericidal killing. J Exp Med (2014) 0.87
Rheumatoid factors: clinical applications. Dis Markers (2013) 0.87
Epitope predictions indicate the presence of two distinct types of epitope-antibody-reactivities determined by epitope profiling of intravenous immunoglobulins. PLoS One (2013) 0.87
Comprehensive peptidomic and glycomic evaluation reveals that sweet whey permeate from colostrum is a source of milk protein-derived peptides and oligosaccharides. Food Res Int (2014) 0.86
Amyloid formation in light chain amyloidosis. Curr Top Med Chem (2012) 0.86
IgA subclass switch recombination in human mucosal and systemic immune compartments. Mucosal Immunol (2013) 0.85
Site-Specifically Labeled Immunoconjugates for Molecular Imaging-Part 1: Cysteine Residues and Glycans. Mol Imaging Biol (2016) 0.85
Alterations in serum immunoglobulin levels in workers occupationally exposed to trichloroethylene. Carcinogenesis (2012) 0.84
Antibody deficiency in chronic rhinosinusitis: epidemiology and burden of illness. Am J Rhinol Allergy (2013) 0.83
Immunological mechanisms for desensitization and tolerance in food allergy. Semin Immunopathol (2012) 0.83
Crystal structure of an anti-Ang2 CrossFab demonstrates complete structural and functional integrity of the variable domain. PLoS One (2013) 0.83
Autoimmune synaptopathies. Nat Rev Neurosci (2016) 0.82
Human IgG2- and IgG4-expressing memory B cells display enhanced molecular and phenotypic signs of maturity and accumulate with age. Immunol Cell Biol (2017) 0.82
Immune markers characteristic for asymptomatically infected and diseased Entamoeba histolytica individuals and their relation to sex. BMC Infect Dis (2014) 0.82
Detection of Mycoplasma genitalium-reactive cervicovaginal antibodies among infected women. Clin Vaccine Immunol (2011) 0.82
In vitro assessment of the immunological significance of a human monoclonal antibody directed to the influenza a virus nucleoprotein. Clin Vaccine Immunol (2013) 0.82
The mouse antibody heavy chain repertoire is germline-focused and highly variable between inbred strains. Philos Trans R Soc Lond B Biol Sci (2015) 0.82
Toxicological effects of nickel chloride on IgA+ B Cells and sIgA, IgA, IgG, IgM in the intestinal mucosal immunity in broilers. Int J Environ Res Public Health (2014) 0.82
Computational analyses of an evolutionary arms race between mammalian immunity mediated by immunoglobulin A and its subversion by bacterial pathogens. PLoS One (2013) 0.82
A patterned recombinant human IgM guides neurite outgrowth of CNS neurons. Sci Rep (2013) 0.81
IgE-based Immunotherapy of Cancer -A Comparative Oncology Approach. J Carcinog Mutagen (2014) 0.81
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies. Mol Ther Methods Clin Dev (2016) 0.80
Structural integrity of the antigen is a determinant for the induction of T-helper type-1 immunity in mice by gene gun vaccines against E. coli beta-galactosidase. PLoS One (2014) 0.80
Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins. Front Immunol (2016) 0.80
Protein expression in human cumulus cells as an indicator of blastocyst formation and pregnancy success. J Assist Reprod Genet (2016) 0.79
Strategies to stabilize compact folding and minimize aggregation of antibody-based fragments. Adv Biosci Biotechnol (2013) 0.79
Cynomolgus and pigtail macaque IgG subclasses: characterization of IGHG genes and computational analysis of IgG/Fc receptor binding affinity. Immunogenetics (2014) 0.79
Optimized adenovirus-antibody complexes stimulate strong cellular and humoral immune responses against an encoded antigen in naive mice and those with preexisting immunity. Clin Vaccine Immunol (2011) 0.79
Leporid immunoglobulin G shows evidence of strong selective pressure on the hinge and CH3 domains. Open Biol (2014) 0.79
Crystal structure of a human single domain antibody dimer formed through V(H)-V(H) non-covalent interactions. PLoS One (2012) 0.78
IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test. PLoS Negl Trop Dis (2014) 0.78
Differential Effects of Environmental and Genetic Factors on T and B Cell Immune Traits. Cell Rep (2016) 0.78
ISSLS PRIZE IN CLINICAL SCIENCE 2017: Is infection the possible initiator of disc disease? An insight from proteomic analysis. Eur Spine J (2017) 0.78
Advances in Molecular Imaging Strategies for In Vivo Tracking of Immune Cells. Biomed Res Int (2016) 0.77
Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients. Int J Med Sci (2015) 0.77
Fungal vaccines and immunotherapeutics. Cold Spring Harb Perspect Med (2014) 0.77
Generation of Anti-Boa Immunoglobulin Antibodies for Serodiagnostic Applications, and Their Use to Detect Anti-Reptarenavirus Antibodies in Boa Constrictor. PLoS One (2016) 0.77
Genomic V exons from whole genome shotgun data in reptiles. Immunogenetics (2014) 0.77
IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis. Arthritis Res Ther (2013) 0.77
IgG Fab fragments forming bivalent complexes by a conformational mechanism that is reversible by osmolytes. J Biol Chem (2012) 0.77
Selection of apoptotic cell specific human antibodies from adult bone marrow. PLoS One (2014) 0.77
Bactericidal Immunity to Salmonella in Africans and Mechanisms Causing Its Failure in HIV Infection. PLoS Negl Trop Dis (2016) 0.76
An automated algorithm for extracting functional immunologic V-genes from genomes in jawed vertebrates. Immunogenetics (2013) 0.76
SpotLight Proteomics: uncovering the hidden blood proteome improves diagnostic power of proteomics. Sci Rep (2017) 0.76
Increased levels of IgG antibodies against human HSP60 in patients with spondyloarthritis. PLoS One (2013) 0.76
Characterization of the torafugu (Takifugu rubripes) immunoglobulin heavy chain gene locus. Immunogenetics (2015) 0.76
Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells. MAbs (2015) 0.76
Development of serum antibodies during early infancy in rhesus macaques: implications for humoral immune responses to vaccination at birth. Vaccine (2014) 0.76
Fcγ Receptor Heterogeneity in Leukocyte Functional Responses. Front Immunol (2017) 0.75
Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis. Sci Rep (2017) 0.75
The Cloning and Expression of Human Monoclonal Antibodies: Implications for Allergen Immunotherapy. Curr Allergy Asthma Rep (2016) 0.75
Systemic and immunotoxicity of pristine and PEGylated multi-walled carbon nanotubes in an intravenous 28 days repeated dose toxicity study. Int J Nanomedicine (2017) 0.75
Toxoplasma-SPECIFIC IgG SUBCLASS ANTIBODY RESPONSE IN CEREBROSPINAL FLUID SAMPLES FROM PATIENTS WITH CEREBRAL TOXOPLASMOSIS. Rev Inst Med Trop Sao Paulo (2015) 0.75
Cynomolgus macaque (Macaca fascicularis) immunoglobulin heavy chain locus description. Immunogenetics (2016) 0.75
Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity. Microbiol Mol Biol Rev (2016) 0.75
Immune Aspects of Female Infertility. Int J Fertil Steril (2016) 0.75
Antibody fragments as nanoparticle targeting ligands: a step in the right direction. Chem Sci (2016) 0.75
Salivary Immunoglobulin Gene Expression in Patients with Caries. Open Access Maced J Med Sci (2017) 0.75
The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches. J Immunol Res (2016) 0.75
Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds. Front Immunol (2017) 0.75
A comparison of biophysical characterization techniques in predicting monoclonal antibody stability. MAbs (2016) 0.75
Camelid Single-Domain Antibodies As an Alternative to Overcome Challenges Related to the Prevention, Detection, and Control of Neglected Tropical Diseases. Front Immunol (2017) 0.75
Reconstituted B cell receptor signaling reveals carbohydrate-dependent mode of activation. Sci Rep (2016) 0.75
B Cell-Based Seamless Engineering of Antibody Fc Domains. PLoS One (2016) 0.75
Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains. Int J Clin Exp Pathol (2015) 0.75
Fish Immunoglobulins. Biology (Basel) (2016) 0.75
B cell immunology for the clinician. Pediatr Infect Dis J (2011) 0.75
Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development. Front Immunol (2017) 0.75
Somatic generation of antibody diversity. Nature (1983) 28.06
The immunoglobulin superfamily--domains for cell surface recognition. Annu Rev Immunol (1988) 12.87
Naturally occurring antibodies devoid of light chains. Nature (1993) 7.35
The immunoglobulin heavy chain variable region (Igh-V) locus in the mouse. I. One hundred Igh-V genes comprise seven families of homologous genes. Eur J Immunol (1984) 5.33
The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol (2007) 4.96
Immunoglobulin genes. Annu Rev Immunol (1983) 3.72
Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains. J Mol Biol (1994) 3.57
Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad Sci U S A (2008) 3.55
Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity (1998) 3.16
The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J Exp Med (1998) 2.56
Fc-receptors as regulators of immunity. Adv Immunol (2007) 2.38
Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. Int Immunol (2006) 2.32
Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences. Adv Immunol (2005) 2.19
Transcriptional networks in developing and mature B cells. Nat Rev Immunol (2005) 2.07
Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. J Mol Biol (1997) 2.03
Engineered human IgG antibodies with longer serum half-lives in primates. J Biol Chem (2003) 2.03
Role of natural and immune IgM antibodies in immune responses. Mol Immunol (2000) 1.84
Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv Immunol (2007) 1.80
One-megabase sequence analysis of the human immunoglobulin lambda gene locus. Genome Res (1997) 1.77
Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. Glycobiology (2006) 1.69
Roundtrip ticket for secretory IgA: role in mucosal homeostasis? J Immunol (2007) 1.61
General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold. J Biol Chem (2008) 1.60
Mucosal immunoglobulins. Immunol Rev (2005) 1.60
In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc Natl Acad Sci U S A (2008) 1.44
Structural analysis of the nurse shark (new) antigen receptor (NAR): molecular convergence of NAR and unusual mammalian immunoglobulins. Proc Natl Acad Sci U S A (1998) 1.42
Somatic hypermutation of human immunoglobulin heavy chain genes: targeting of RGYW motifs on both DNA strands. Eur J Immunol (1998) 1.35
Antibody diversification by somatic mutation: from Burnet onwards. Immunol Cell Biol (2008) 1.34
Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers. J Immunol (2000) 1.34
The immunoglobulin constant region contributes to affinity and specificity. Trends Immunol (2008) 1.32
Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors. Proc Natl Acad Sci U S A (2008) 1.31
Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1. J Virol (2001) 1.29
Structural insight into pre-B cell receptor function. Science (2007) 1.29
IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions. Proc Natl Acad Sci U S A (2008) 1.27
Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol Lett (2006) 1.21
Antibody structure and the evolution of immunoglobulin V gene segments. Semin Immunol (1994) 1.17
Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases. Adv Immunol (2007) 1.09
The immunoglobulin kappa light chain repertoire expressed in the synovium of a patient with rheumatoid arthritis. Arthritis Rheum (1992) 1.06
The neutralization properties of a HIV-specific antibody are markedly altered by glycosylation events outside the antigen-binding domain. J Immunol (2007) 1.06
Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody. Immunol Lett (2006) 1.03
Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region. J Immunol Methods (2005) 1.01
The riddle of the dual expression of IgM and IgD. Immunology (2006) 0.99
Pathogenic human monoclonal antibody against desmoglein 3. Clin Immunol (2006) 0.98
Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions. Clin Immunol (2005) 0.96
The genetics of antibody diversity. Sci Am (1982) 0.95
Demystified...recombinant antibodies. J Clin Pathol (2004) 0.91
Binding and neutralization activity of human IgG1 and IgG3 from serum of HIV-infected individuals. AIDS Res Hum Retroviruses (2003) 0.90
Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns. J Am Acad Dermatol (2003) 0.90
Human immunoglobulin subclasses. Diagn Clin Immunol (1987) 0.89
Structure and immunological action of the human pathogen Moraxella catarrhalis IgD-binding protein. Crit Rev Immunol (2006) 0.88
Gm typing by immunoglobulin heavy-chain gene RFLP analysis. Am J Hum Genet (1988) 0.86
Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120. Science (2009) 4.20
Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody. Proc Natl Acad Sci U S A (2011) 2.39
Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J Immunol (2004) 1.45
Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120. AIDS Res Hum Retroviruses (2003) 0.96
Human single-chain antibodies inhibit replication of human immunodeficiency virus type 1 (HIV-1). AIDS Res Hum Retroviruses (2005) 0.78
Neutralization of HIV by milk expressed antibody. J Acquir Immune Defic Syndr (2013) 0.76